We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Neal Chaisson

Neal F Chaisson MD

Assistant Professor of Medicine and the Program Director of the Critical Care Medicine Fellowship in the Respiratory Institute at Cleveland Clinic, Cleveland, OH

Neal Chaisson, MD, is an Assistant Professor of Medicine and the Program Director of the Critical Care Medicine Fellowship in the Respiratory Institute at Cleveland Clinic.  He joined the Cleveland Clinic in 2013 after completing his fellowship in Pulmonary/Critical Care Medicine at Johns Hopkins University.  His primary area of expertise is in the evaluation and treatment of patients with pulmonary arterial hypertension (PAH) and pulmonary complications of congenital heart disease.  Dr Chaisson has active clinical and research interests in the hemodynamic evaluation of PAH patients and in medical education. He has been a nominee for the Distinguished Teacher Award from the Internal Medicine Residency Program in 2015 and 2016 and was presented with the award in 2017. In 2019 he was a  nominee for the Internal Medicine Career Mentorship award and was awarded the Respiratory Institute’s Best Teacher Award for Critical Care Medicine.  He directs educational training for the Pulmonary Vascular Disease Program.  He also maintains a strong interest in critical care medicine and in the understanding of hemodynamic parameters surrounding shock assessment.

Disclosures

Dr. Chaisson's Disclosures:

  1. Gilead Pharmaceuticals – Speaker’s Bureau (<$10,000)
  2. Bayer Pharmaceuticals – Speaker’s Bureau, Advisory Board (<$10,000)
  3. Actelion Pharmaceuticals – Advisory Board ($10-20,000)